Zinc finger and BTB domain-containing protein 32 is a protein that in humans is encoded by the 1960 bp ZBTB32gene. The 52 kDa protein is a transcriptional repressor and the gene is expressed in T and B cells upon activation, but also significantly in testis cells. It is a member of the Poxviruses and Zinc-finger and Krüppel family of proteins, and was identified in multiple screens involving either immune cell tumorigenesis or immune cell development. The protein recruits histone modification enzymes to chromatin to affect gene activation. ZBTB32 recruits corepressors, such as N-CoR and HDACs to its target genes, induces repressive chromatin states and acts cooperatively with other proteins, e.g. with Blimp-1, to suppress the transcription of genes. It contains a N-terminal BTB/POZ domain or a SKP1/BTB/POZ domain, and three C-terminal zinc fingers, Znf_C2H2_sf., Znf_C2H2_type domain, a Znf_RING/FYVE/PHD domain, followed by a putative UBZ4 domain.
Nomenclature
Zinc finger and BTB domain-containing protein 32 is also known as:
Zinc-finger elbow-related proline domain protein 2
GATA binding protein
Immune system
The expression of ZBTB32 is induced by inflammatory cytokines and promotes proliferation of natural killer cells. Zbtb32 knockout mice show a trend to develop type 1 diabetes, although the difference is not statistically different. Furthermore the Zbtb32 do not show a difference in lymphocyte proliferation, possibly due to compensation from other genes.
Cancer
ZBTB32 is highly expressed spermatogonial stem cells, in hematopoietic stem and progenitor cells, in diffuse large B-cell lymphoma and appears to suppress the immune system by silencing the CIITA gene. The transcription factor gene GATA3 is altered in mammary tumors. Down-regulation of GATA3 expression and activity by the Zinc-finger elbow-related proline domain protein 2, whereas Zbtb32 facilitates Zpo2 targeting to the GATA3 promoter, results in the development of aggressive breast cancers. A DNA methylation correlation network was built based on the methylation correlation between differentially methylated genes. A survival analysis of candidate biomarkers was performed. One of eight biomarkers and hub genes identified in colon cancer is ZBTB32. The expression of Zbtb32 is upregulated after exposure to cisplatin.
